Franceschi studied Pharmaceutical Chemistry and Technology at the University of Pisa. After graduating in 2010, she worked as research fellow in the Proteomic Laboratory of the Institute of Clinical Physiology, National Research Council (IFC-CNR) of Pisa. In 2011 Franceschi started her PhD in Biological and Molecular Sciences - Program of Molecular and Experimental Oncology at the Molecular Pathology Laboratory of Santa Chiara University Hospital of Pisa. She also spent one academic year as a visiting PhD student at the Memorial Sloan-Kettering Cancer Center of New York in the Human Oncology and Pathogenesis Program (HOPP). Franceschi joined Pisa Science Foundation in 2014 as a Postdoc Fellow, following the completion of her PhD.

Her Research is focussed to Despite the latest advances in surgery, radiological assessment, and radiotherapy treatment, the incidence of glioblastoma is roughly comparable to that of mortality, and the prognosis is almost always related to intracranial progression after surgery and radio-chemotherapy.